相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells
Brian A. Walker et al.
BLOOD (2013)
Diverse Mechanisms of Somatic Structural Variations in Human Cancer Genomes
Lixing Yang et al.
CELL (2013)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Super-Enhancers in the Control of Cell Identity and Disease
Denes Hnisz et al.
CELL (2013)
Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants
Stephen C. J. Parker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
MYC addiction: a potential therapeutic target in MM
W. Michael Kuehl et al.
BLOOD (2012)
Frequent PVT1 Rearrangement and Novel Chimeric Genes PVT1-NBEA and PVT1-WWOX Occur in Multiple Myeloma with 8q24 Abnormality
Hisao Nagoshi et al.
CANCER RESEARCH (2012)
Molecular pathogenesis of multiple myeloma and its premalignant precursor
W. Michael Kuehl et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Germline Deletion of Igh 3′ Regulatory Region Elements hs 5, 6, 7 (hs5-7) Affects B Cell-Specific Regulation, Rearrangement, and Insulation of the Igh Locus
Sabrina A. Volpi et al.
JOURNAL OF IMMUNOLOGY (2012)
The role of CTCF binding sites in the 3′ immunoglobulin heavy chain regulatory region
Barbara K. Birshtein
Frontiers in Genetics (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Mapping of Chromosome 1p Deletions in Myeloma Identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as Being Genes in Regions Associated with Adverse Survival
Kevin D. Boyd et al.
CLINICAL CANCER RESEARCH (2011)
Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma
Dirk Hose et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma
W-J Chng et al.
LEUKEMIA (2011)
Initial genome sequencing and analysis of multiple myeloma
Michael A. Chapman et al.
NATURE (2011)
Mapping and analysis of chromatin state dynamics in nine human cell types
Jason Ernst et al.
NATURE (2011)
Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells
Ernesto Perez-Persona et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
R. A. Kyle et al.
LEUKEMIA (2010)
Frequent Upregulation of MYC in Plasma Cell Leukemia
Laura Chiecchio et al.
GENES CHROMOSOMES & CANCER (2009)
Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case
Laura Chiecchio et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
Angela Dispenzieri et al.
BLOOD (2008)
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies
Marta Chesi et al.
CANCER CELL (2008)
Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors
Ana Gabrea et al.
GENES CHROMOSOMES & CANCER (2008)
Genetic events in the pathogenesis of multiple myeloma
W. J. Chng et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
Herve Avet-Loiseau et al.
BLOOD (2007)
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
John D. Shaughnessy et al.
BLOOD (2007)
Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas
P. Bertrand et al.
LEUKEMIA (2007)
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis
Fenghuang Zhan et al.
BLOOD (2007)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
Distinguishing primary and secondary translocations in multiple myeloma
Ana Gabrea et al.
DNA REPAIR (2006)
Molecular pathogenesis and a consequent classification of multiple myeloma
PL Bergsagel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma
PL Bergsagel et al.
BLOOD (2005)
The spectrum of lymphoma with 8q24 aberrations: A clinical, pathological and cytogenetic study of 87 consecutive cases
WY Au et al.
LEUKEMIA & LYMPHOMA (2004)
Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma
S Fabris et al.
GENES CHROMOSOMES & CANCER (2003)
Transcriptional analysis of the B cell germinal center reaction
U Klein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development
FH Zhan et al.
BLOOD (2003)
Transformation of follicular lymphoma to diffuse large-cell lymphoma:: Alternative patterns with increased or decreased expression of c-myc and its regulated genes
IS Lossos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells
FH Zhan et al.
BLOOD (2002)
Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors
H Avet-Loiseau et al.
BLOOD (2001)
Chromosome translocations in multiple myeloma
PL Bergsagel et al.
ONCOGENE (2001)
Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma
JR Sawyer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia
HG Drexler et al.
LEUKEMIA RESEARCH (2000)
Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma
YP Shou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
